Previous Close | 20.46 |
Open | 20.56 |
Bid | 20.55 x 800 |
Ask | 20.56 x 1100 |
Day's Range | 20.36 - 21.02 |
52 Week Range | 12.05 - 34.98 |
Volume | |
Avg. Volume | 499,015 |
Market Cap | 1.162B |
Beta (5Y Monthly) | 0.92 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ALL-REMOTE COMPANY/WILMINGTON, Del., March 19, 2024--Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company’s new Chief Technology Officer.
WILMINGTON, Del., March 14, 2024--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024.
WILMINGTON, Del., February 27, 2024--Phreesia announces that its Chief Clinical Officer Hilary Hatch, PhD, has been selected to participate in NQF's 2024-2025 Leadership Consortium.